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Bloodstream infections (BSIs) continue to rep-resent a significant source of morbidity and 
mortality in paediatric wards affecting primarily 
paediatric and neonatal intensive care units [1-3].
BSIs have been traditionally classified as health-
care-associated (HA) or community-acquired 
(CA). Nowadays complex medical services are 
increasingly provided in the community setting. 
So that BSIs occurring in community based pa-
tients may share many characteristics with HA 
infections such as associated comorbid diseases, 
increased risk for antimicrobial resistance and 
higher mortality [4-5]. The aim of this study is to 
investigate clinical and microbiological features 
and outcome of medical care related and labora-
tory-confirmed bloodstream infections (LCBIs) in 
children admitted to a paediatric hospital, or with 
history of a recent hospital admission or exposure 
to serious medical care in the outpatient setting.
n PAtientS AnD MetHoDS
A prospective observational study was performed 
between the 1st of June 2010 and the 31st of May 
2011 at Regina Margherita Children’s Hospital 
(Turin, Italy), a Paediatric referral teaching hospi-
tal comprehensive of medical and surgical wards 
and transplant divisions (solid organs and stem 
cells). 
In order to identify all septic episodes, Centers 
for Disease Control and Prevention (CDC) and 
National Healthcare Safety Network (NHS) sur-
veillance definitions of LCBIs and central line-
associated BSIs (CLABSIs) were integrated with 
additional criteria. All patients with clinical signs 
of sepsis (fever, tachycardia, hypotension, etc.), 
positive laboratory markers of infection (increase 
of inflammatory markers, such as white blood 
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cells count, C reactive protein, procalcitonin) 
and one or more of the following tests positive: 
blood culture for aerobic and anaerobic bacteria 
and fungi (BacT/ALERT, bioMérieux), multiplex 
real time Polymerase Chain Reaction (PCR) test 
on blood (LightCycler SeptiFast, Roche Diagnos-
tics) and culture on intravascular device tip, were 
recruited [6-11]. Only LCBIs occurred in children 
with recent history of healthcare exposure were 
included in the analysis of the study. LCBIs were 
identified as healthcare-associated (HA) accord-
ing to 1996-2008 CDC/NHSN definitions [7, 10]. 
As previously proposed, we defined as healthcare 
outpatient associated (HOA) LCBIs those septic 
episodes occurring at the time of hospital admis-
sion or within 48 hours upon admission in previ-
ously home-based patients with at least one of the 
following characteristics: (I) intravenous therapy, 
chemotherapy or haemodialysis in the 30 days 
before BSI onset; (II) Intensive Care Unit hospi-
talization lasting two or more days in the 90 days 
before BSI onset [4, 5]. 
All cases of positive microbiological tests not as-
sociated with clinical and/or serological signs of 
infection and not included in the previous criteria 
for LCBIs were considered sample contamination.
Basing on data provided by antibiogram, the an-
tibiotic treatment was defined as adequate when 
the microorganism isolated was sensitive to the 
antibiotic administered. If susceptibility testing 
was not available the antibiotic treatment was 
considered adequate when the pathogen isolated 
was theoretically sensitive to the antibiotic ad-
ministered and an improvement of patient clini-
cal conditions after treatment was observed.
Prematurity was defined as birth before 37 weeks 
of gestation age. Five patients aged >18 years old 
affected by chronic diseases followed by our cen-
tre beyond the adult age were included because 
our purpose was to describe characteristics of 
sepsis in the whole hospital population.
Incidence (ratio) of HA-LCBIs was expressed as 
the total number of septic episodes per 1,000 hos-
pitalized patients. Incidence density (rate) was 
calculated as the total number of bloodstream 
infections per 1,000 inpatient days. Incidence of 
HOA-LCBIs was not calculated due to the impos-
sibility of inferring the exact number of children 
at risk. The total number of admissions was the 
denominator used to calculate the CLABSI inci-
dence since the study design did not provide a 
control group and data about CVC-days were not 
obtainable.
Risk of developing LCBI in males and females 
was evaluated by chi-square test with one degree 
of freedom. The two-tailed p value was consid-
ered statistically significant if <0.05.
n reSUltS
A total of 140 episodes of LCBI occurred in 131 
children over one-year of observation (5 children 
presented more than one episode of LCBI): 37 
(26.4%) were classified as healthcare outpatient 
associated, 91 (65.0%) as healthcare associated 
and 12 (8.6%) as community-acquired. In this sur-
vey we only refer to the 128 episodes of medical 
care related LCBIs (healthcare outpatient associat-
ed plus healthcare associated LCBIs). In 195 cases 
the positivity of one or more microbiological test 
was considered as sample contamination. Coagu-
lase-negative staphylococci (CoNS) (84.9%) were 
the most frequent pathogens identified in these 
cases.
Considering both paediatric and neonatal wards, 
there were 14,342 hospital admissions, with a 
HA-LCBIs incidence (ratio) of 13.6/1,000 pa-
tients and an incidence density (rate) of 1.4/1,000 
inpatient days. Forty-seven episodes have oc-
curred in newborns (median age at diagnosis 0.03 
years; IQR (InterQuartile Range) 0.01-0.06 years) 
while 81 episodes have been recorded in infants 
(median age at diagnosis 9.1 years; IQR 3.3-15.4 
years). Median weight at diagnosis was 1.7 kg 
(IQR 0.9-3.0 kg) and 23.8 kg (IQR 14.2-64.0 kg) re-
spectively in newborns and infants. Twenty-one 
episodes (16.4%) of LCBIs occurred in very low 
birth weight babies (birth weight <1.5 kg). Risk of 
developing LCBI was higher in males (p=0.011), 
who presented a total of 85 (66.4%) LCBI, while 
only 43 (33.6%) LCBI were observed in females. 
The 86.7% of episodes regarded patients with se-
rious underlying medical conditions (prematu-
rity 26.1%, cancer 39.1%, hematopoietic stem cell 
transplantation 7.8%, malformative syndromes 
7.8%, dialysis 6.1%, solid organ transplantation 
3.5%, immunosuppression 2.6%, other 7.0%).
Oncology and stem cell transplant divisions, neo-
natal intensive care unit, neonatal wards and ne-
phrology division counted respectively the 40.6%, 
26.6%, 7.0%, and 6.3% of episodes (Table 1).
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A total of 107 episodes (83.6%) of HA and HOA 
LCBIs occurred in children with central venous 
catheter (CVC), but only 62 (48.4%) episodes were 
CLABSI. Sources of infections in the remaining 
cases were throat and upper airways (12.5%), lung 
(10.2%), gastrointestinal tract (7.8%), urinary tract 
(3.1%), ears (0.8%), other (9.4%), unknown (7.8%). 
Positive blood culture alone was the main test to 
diagnose LCBIs (79.7%). A second positive blood 
culture was required if the microorganism iden-
tified was a common commensal (such as Cory-
nebacterium spp., Bacillus spp., Propionibacterium 
spp., CoNS, Streptococcus viridans, Aerococcus spp., 
Micrococcus spp.). Other cultural and molecular 
tests performed were: PCR detection of patho-
gen DNA on blood (1.6%), positive blood culture 
and PCR detection of pathogen DNA on blood 
(3.1%), positive blood and removed CVC tip cul-
tures (12.5%), PCR detection of pathogen DNA 
on blood and positive removed CVC tip culture 
(0.8%), PCR detection of pathogen DNA on blood 
and positive blood and removed CVC tip cultures 
(1.6%), positive coagglutination test on cerebro-
spinal fluid and positive blood/cerebrospinal 
fluid cultures (0.8%). 
Gram positive and Gram negative bacteria were 
isolated in the 62.3% and 30.4% of the episodes, 
respectively; fungi were responsible for the re-
maining 7.2% (Table 2). Concerning the distri-
bution of antimicrobial resistance among Gram 
positive bacteria, methicillin-resistant was ob-
served in 9.5% of Staphylococcus aureus (MRSA) 
and in 78.4% of coagulase-negative staphylococci 
(CoNS). Pseudomonas aeruginosa was isolated in 
7 children: in 5 cases it was a drug-susceptible 
strain, while in 2 cases drug susceptibility was not 
available because the bacteria was identified by 
PCR test only.
Empirical antibiotic therapy administered at onset 
of symptoms was adequate in 105 cases (82.0%). In 
the remaining cases, appropriate antibiotic treat-
ment was administered within 24 hours in 8 cases 
(6.3%), within 48 hours in 2 cases (1.6%), within 
72 hours or more in 12 cases (9.4%). One patient 
never received an adequate antibiotic treatment 
because he died for an end-stage haematological 
cancer 24 hours after sample collection for mi-
crobiological tests. Five patients died because of 
LCBIs, corresponding to an overall mortality rate 
of 3.9%: 3 of them were children affected by end-
stage cancer and two were premature newborns 
of extremely low birth weight. Escherichia coli (2 
cases), P. aeruginosa (1 case), Streptococcus agalac-
tiae (1 case) and Enterococcus faecium (1 case) were 
the responsible pathogens isolated.
Among all episodes of LCBIs, we identified 62 
table 1 - Incidence of medical care related laboratory-confirmed bloodstream infection (LCBI) by specialty.
HOA-LCBIa HA-LCBIb Total Incidence of HA-LCBIb






Neonatology unit 0 9 9 (7.0) 1.2 0.3
Neonatal intensive care unit 1 33 34 (26.6) 91.7 3.4
Oncology and stem cell 
transplant center
27 25 52 (40.6) 30.7 3.6
Infectious diseases unit 1 3 4 (3.1) 6.9 0.8
Cardiac surgery unit 0 4 4 (3.1) 24.5 1.6
Neurosurgery unit 0 1 1 (0.8) 3.1 0.4
Gastroenterology unit 0 2 2 (1.6) 9.8 1.5
Pneumology unit 0 3 3 (2.3) 12.0 1.0
Emergence department 0 2 2 (1.6) 2.3 0.4
Orthopedic unit 0 1 1 (0.8) 2.7 0.8
Pediatric intensive care unit 0 1 1 (0.8) 26.3 0.9
Neonatal surgery 0 4 4 (3.1) 61.5 1.8
General pediatrics 2 1 3 (2.3) 3.5 0.5
Nephrology unit 6 2 8 (6.3) 9.5 0.8
Total 37 91 128(100.0) 13.6 1.4
aHOA-LCBI: healthcare outpatient associated laboratory confirmed bloodstream infection. bHA-LCBI: healthcare associated laboratory confirmed 
bloodstream infection
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cases of CLABSI, representing the 48.4% of LCBIs: 
23 (37.1%) of them were HOA and 39 (62.9%) HA. 
Thirty-two (51.6%) cases affected long-term tun-
neled CVCs and 30 (48.4%) non tunneled CVCs. 
The incidence (ratio) of HA-CLABSI was 1.9/1,000 
patients for tunneled CVC and 3.9/1,000 for non-
tunneled ones, while incidence density (rate) was 
0.2/1,000 and 0.4/1,000 inpatient days respec-
tively. No significant seasonal variability was ob-
served in the incidence of CLABSI. CoNS (39.7%) 
and S. aureus (14.7%) were the pathogens most 
frequently isolated. Intravascular device was re-
moved in the 40.6% of CLABSIs related to tun-
neled catheter and in the 90.0% of non-tunneled 
catheters. All CLABSI episodes had a good out-
come.
Forty seven neonatal sepsis were observed, rep-
resenting the 36.7% of all cases: 46 (97.9%) were 
classified as HA and only one (2.1%) as HOA. 
Excluding all healthy infants discharged from 
the neonatal wards and 9 episodes of LCBI oc-
curred outside the wards, the incidence (ratio) of 
neonatal HA-LCBIs was 102.8/1,000 admissions 
and the incidence density (rate) was 3.8/1,000 
inpatient days. With reference to risk condition, 
prematurity was observed in the 59.6% of the ne-
onatal LCBI. CoNS (35.4%), S. aureus (12.5%) and 
S. agalactiae (10.4%) were the predominant patho-
gens responsible for LCBIs. Mortality rate was 
4.3%.
Fungal infections represented 7.8% of LCBIs cases 
(10 episodes recorded): 7 were CLABSIs while all 
the others occurred in immunocompromised pa-
tients. All the episodes of fungal LCBI recovered 
after appropriate antifungal treatment and CVC 
removal.
n DiScUSSion
Medical care related LCBIs represent a significant 
health problem in the paediatric setting due to 
the high mortality and morbidity rates reported, 
especially among newborns and children with 
table 2 - Pathogens isolated from children affected by medical care related laboratory-confirmed bloodstream 
infections (LCBIs).
No. pathogens isolated (%)
Pathogens HOA-LCBIa HA-LCBIb Medical care related LCBIs
Gram positive 19 (47.5) 67 (68.4) 86 (62.3)
Staphylococcus aureus 10 (25.0) 11 (11.2) 21 (15.2)
Coagulase-negative staphylococci 6 (15.0) 31 (31.6) 37 (26.8)
Streptococcus agalactiae 0 (0.0) 5 (5.1) 5 (3.6)
Streptococcus pneumoniae 0 (0.0) 1 (1.0) 1 (0.7)
Other streptococci 1 (2.5) 6 (6.1) 7 (5.1)
Enterococcus faecium 1 (2.5) 4 (4.1) 5 (3.6)
Enterococcus faecalis 0 (0.0) 5 (5.1) 5 (3.6)
Other 1 (2.5) 4 (4.1) 5 (3.6)
Gram negative 21 (52.5) 21 (21.4) 42 (30.4)
Escherichia coli 4 (10.0) 8 (8.2) 12 (8.7)
Klebsiella spp. 3 (7.5) 4 (4.1) 7 (5.1)
Enterobacter cloacae 2 (5.0) 1 (1.0) 3 (2.2)
Acinetobacter spp. 3 (7.5) 0 (0.0) 3 (2.2)
Pseudomonas aeruginosa 2 (5.0) 5 (5.1) 7 (5.1)
Sphingomonas paucimobilis 0 (0.0) 1 (1.0) 1 (0.7)
Haemophilus influenzae type b 0 (0.0) 1 (1.0) 1 (0.7)
Other 7 (17.5) 1 (1.0) 8 (5.8)
Fungi 0 (0.0) 10 (10.2) 10 (7.2)
Candida albicans 0 (0.0) 4 (4.1) 4 (2.9)
other Candida spp 0 (0.0) 6 (6.1) 6 (4.3)
Total* 40 (100.0) 98 (100.0) 138 (100.0)
aHOA-LCBI: healthcare outpatient associated laboratory confirmed bloodstream infection. bHA-LCBI: healthcare associated laboratory confirmed 
bloodstream infection. *10 LCBI were polymicrobial.
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chronic comorbidities. In recent years some Au-
thors proposed a sub-classification of community 
onset BSIs into proper community-acquired and 
healthcare outpatient associated infection as a 
consequence of the increased opportunities of pro-
viding complex medical services also in the com-
munity setting [4, 5]. Since HA and HOA LCBIs 
occur in patients with specific characteristics (un-
derlying diseases, predisposing conditions, medi-
cal exposure), and share epidemiological features, 
causative pathogens and mortality rates, they have 
been analyzed altogether. Few monocentric stud-
ies investigated LCBIs considering both general 
and specialized wards and intensive care units in 
a paediatric hospital, giving a general overview of 
the phenomenon in children. Many authors have 
evaluated subcategories of children, as those ad-
mitted to high risk single departments (paediatric 
or neonatal intensive care units, oncology or car-
diac surgery services) or have focused on LCBIs 
caused by specific pathogens, such as S. agalactiae, 
Streptococcus pneumoniae, and S. aureus. Instead, 
our purpose was an accurate and comprehensive 
epidemiological description of LCBIs clinical and 
microbiological features possibly related to signif-
icant exposure to relevant medical care. 
Incidence (ratio) of LCBIs observed in our survey 
(13.6/1,000 patients) was slightly higher than that 
reported in literature [12-14]. In addition to differ-
ent definitions of LCBI used, this difference could 
be explained by several factors. First of all, the in-
clusion in the present survey of high risk wards, 
such as paediatric and neonatal intensive care 
units, solid organs and stem cells transplantation 
units and cardiac and neurosurgery services: in-
deed, neonatal wards and neonatal intensive care 
units accounted for 33.6% of all LCBIs. Secondly, 
also highly probable LCBI episodes supported by 
positive molecular tests other than blood culture 
were included in this survey for a complete over-
view of the disease [15]. Finally, study population 
included some patients aged >18 years, because 
paediatric patients suffering from chronic diseas-
es are generally followed at our centre beyond the 
adult age.
Categories more vulnerable to LCBIs were on-
cologic children (40.6%) and newborns (36.7%). 
Among the latter, prematurity and very low birth 
weight were the conditions more often associated 
with LCBIs and CoNS were the main responsible 
pathogens in newborns, as observed elsewhere 
[16-18]. Few episodes occurred in intensive care 
unit and cardiac surgery service, probably as 
a result of particular effort into prevention pro-
grams and education of medical and nursing staff 
(protocols for hand-washing, CVC management, 
use of antimicrobial-coated CVC) together with a 
proper administration of antibiotic therapy.
Similarly to other surveys, CoNS, S. aureus, and 
streptococci were the most frequent responsible 
pathogens for LCBIs, while the principal causa-
tive agents among Gram negative bacteria were E. 
coli, Klebsiella spp., and P. aeruginosa [18-20]. Con-
sidering HOA and HA LCBIs separately, Gram 
negatives were responsible for the majority of ep-
isodes (52.5 %) in the first category, while Gram 
positives were prevalent among HA-LCBIs (the 
68.4% of cases). As a matter of fact, HOA-LCBIs 
usually occur in chronic patients more suscepti-
ble to Gram negative infections while the majority 
of HA-LBSIs affect newborns or children with an 
indwelling CVC, in which CoNS are frequently 
isolated. Candida spp were less represented than 
in other studies (7.2% vs 9.3%). No deaths for can-
didemia occurred during the observation period, 
despite the high mortality rate due to Candida spp 
reported in literature, probably as a consequence 
of the extensive use of antifungal prophylaxis 
with fluconazole in high risk children [18, 21-23]. 
LCBIs caused by MRSA, oxacillin-resistant CoNS 
and Multi-Drug Resistant (MDR) P. aeruginosa 
were less frequent than in other studies [14, 18-20, 
24-26]. This may be explained by a low prevalence 
of resistant pathogens in paediatric population 
compared to the overall national rates including 
mostly adults. Children present naturally low risk 
of infections caused by antibiotic-resistant micro-
organisms compared with adults, but no data 
about antibiotic-resistance primarily in children 
is actually available for a proper comparison [24].
Overall mortality rate was lower than data report-
ed in literature [13, 18, 20]. All deaths involved 
critically ill children with serious underlying dis-
eases, as prematurity and end-stage cancer, who 
had received a prompt and appropriate antibiotic 
treatment. The cause of death has been assigned 
to infection and not to other causes because a 
rapid deterioration of the general condition of 
the children was observed concomitantly to the 
development of the infectious disease, which pre-
cipitated already severely compromised clinical 
conditions. 
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To calculate CLABSI incidence, the total number of 
admissions was the denominator used since no con-
trol group was provided for by the study design. Con-
sequently, it was not possible to compare our results 
with other surveys that used CVC-days as denomina-
tor [27-30]. CLABSI mainly occurred in newborns, pa-
tients with cancer or children who had undergone sol-
id organ or stem cells transplantation, major surgery 
or dialysis. In the present survey, CVC was removed 
only in the 40.6% of CLABSI involving tunnelled 
CVC. In some cases a salvage effort with lock-therapy 
was made when removal was deemed unfeasible due 
to concomitant conditions (thrombocytopenia, unsta-
ble critical conditions, difficult venous access in chil-
dren with absolute needs such as dialysis or intrave-
nous therapy) [31]. In other cases CVC was removed 
after multiple episodes of CLABSI involving the same 
CVC. In spite of the relatively low rate of CVC remov-
al, all CLABSI recovered after appropriate systemic 
and local (lock) antimicrobial therapy. 
In conclusion, we observed encouraging and reas-
suring results in terms of epidemiology, clinical man-
agement and outcome of paediatric LCBIs, although 
sepsis continues to represent a significant source 
of morbidity and mortality in newborns and 
oncologic children, so that a particular care 
should be encouraged in the management of 
these high risk categories. A prompt and ap-
propriate antimicrobial treatment is associated 
with positive outcome and reduced mortality 
in most cases. Despite guidelines for preven-
tion of intravascular catheter-related infections 
strongly recommend CVC removal in case of 
BSIs, clinical practice often rules out the possi-
bility of immediate removal because of critical 
and unstable conditions of the patient [32]. 
A limit of this survey is that it was performed 
in a single centre. As medical care related 
LCBIs represent an important cause of morbid-
ity and death in children, further multicentre 
studies with prolonged surveillance time are 
needed to improve the knowledge on clinical 
and microbiological features of LCBIs, to opti-
mize prevention procedures and to reduce the 
impact of these infections in children.
Keywords: HAIs, laboratory-confirmed BSIs, 
paediatric BSIs, sepsis.
The aim of this survey was to describe the incidence, 
epidemiology, microbiology, risk factors and outcome 
of medical care related laboratory-confirmed blood-
stream infections (LCBIs) observed during a twelve-
month prospective study in a Paediatric Teaching 
Hospital in Turin, Italy. Inclusion criteria were clinical 
signs of sepsis and positivity of one or more of the fol-
lowing tests: blood culture, polymerase chain reaction 
for bacterial and fungal DNA on blood, and culture on 
intravascular device tips. In all, 140 episodes of sep-
sis were documented in 131 children: 37 (26.4%) were 
healthcare outpatient-associated, 91 (65.0%) health-
care-associated and 12 (8.6%) community-acquired. 
The overall incidence of healthcare-associated LCBIs 
was 13.6/1,000 hospitalized patients and incidence 
SUMMArY
density 1.4/1,000 inpatient days. The overall mortal-
ity was 3.9%. Forty-seven (36.7%) episodes involved 
newborns and 107 (83.6%) episodes were observed in 
children with an indwelling central venous catheter. 
Coagulase-negative staphylococci (26.8%), Staphylococ-
cus aureus (15.2%), Escherichia coli (8.7%) and Candida 
spp. (7.2%) were responsible for the majority of cases. 
9.5% of S. aureus isolates were methicillin-resistant and 
6.5% of Gram negatives were extended-spectrum be-
ta-lactamase-producing. Incidence and epidemiology 
of medical care related LCBIs were similar to the ex-
isting literature data. LCBIs caused by antibiotic-resist-
ant microorganisms were fewer and mortality rate was 
lower. Most of the LCBIs recorded involved newborns 
and oncological children.
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L’obiettivo di questo studio è la descrizione dell’incidenza, 
dell’epidemiologia, della microbiologia, dei fattori di rischio 
e dell’outcome delle sepsi correlate alle cure e microbiolo-
gicamente documentate (LCBIs) che si sono verificate pres-
so l’Ospedale Infantile Regina Margherita di Torino nel 
corso di un anno di osservazione. Si tratta di uno studio 
prospettico nel quale sono stati arruolati tutti i pazienti 
che presentavano segni clinici e laboratoristici suggestivi 
per sepsi e la positività di almeno uno tra i seguenti esami: 
emocoltura, Polymerase Chain Reaction per la ricerca di 
DNA microbico e fungino su sangue, esame colturale sulla 
punta di cateteri venosi intravascolari asportati. Durante il 
periodo di osservazione sono stati documentati 140 episo-
di settici in 131 bambini: 37 (26.4%) sono stati classificati 
come sepsi correlate all’assistenza medica poiché sviluppa-
tesi in soggetti affetti da patologia cronica, ma non ricove-
rati in ospedale al momento dell’insorgenza dei sintomi, 91 
(65.0%) come sepsi correlate alle cure propriamente dette 
e 12 (8.6%) come sepsi comunitarie, quindi escluse dallo 
studio. L’incidenza di sepsi correlate alle cure è stata di 
riASSUnto
13.6/1,000 pazienti ricoverati e di 1.4/1,000 giorni di ri-
covero, mentre la mortalità è stata del 3.9%. 47 (36.7%) 
episodi hanno coinvolto la popolazione neonatale e 107 
(83.6%) eventi settici si sono verificati in pazienti portatori 
di catetere venoso centrale. I microrganismi isolati più fre-
quentemente sono stati gli stafilococchi coagulasi negativi 
(26.8%), lo Staphylococcus aureus (15.2%), l’Escheri-
chia coli (8.7%) e la Candida spp. (7.2%). Tra gli isolati 
di Staphylococcus aureus, il 9.5% era rappresentato da 
isolati meticillino-resistenti (MRSA) e il 6.5% dei Gram 
negativi identificati era in grado di produrre beta-lattamasi 
ad ampio spettro (ESBL). L’epidemiologia e l’incidenza del-
le sepsi correlate alle cure registrate in questo studio sono 
paragonabili ai valori riportati dalla letteratura, mentre il 
numero di episodi causati da microrganismi antibiotico-
resistenti, così come il tasso di mortalità, si sono dimostrati 
più bassi. La maggior parte degli episodi registrati ha coin-
volto prevalentemente la popolazione neonatale e i bambini 
affetti da patologia oncologica, come riportato anche nei po-
chi studi analoghi disponibili in letteratura.
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